Direct comparison of the A to Z and PROVE IT trials: a second chance to gain a first impression.
B Greg
BG
Brown
D000349:Africa / Q000453:epidemiology; D015906:Angioplasty, Balloon, Coronary / Q000706:statistics & numerical data; D001208:Asia / Q000453:epidemiology; D000069059:Atorvastatin; D001315:Australia / Q000453:epidemiology; D002170:Canada / Q000453:epidemiology; D019090:Case Management; D008078:Cholesterol, LDL / Q000097:blood; D015986:Confounding Factors, Epidemiologic; D004305:Dose-Response Relationship, Drug; D023381:Endpoint Determination; D005060:Europe / Q000453:epidemiology; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015337:Multicenter Studies as Topic; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000628:therapy; D009520:New Zealand / Q000453:epidemiology; D017035:Pravastatin / Q000008:administration & dosage / Q000627:therapeutic use; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D012306:Risk; D019821:Simvastatin / Q000008:administration & dosage / Q000627:therapeutic use; D013020:South America / Q000453:epidemiology; D015607:Stents / Q000706:statistics & numerical data; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D011758:Pyrroles; D014443:Tyrosine; D000069059:Atorvastatin; D019821:Simvastatin; D000077466:Tirofiban; D017035:Pravastatin